INHIBRX BIOSCIENCES INC (INBX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for INBX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| INBX | Director | 58 | [] | [] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Vuori has served as a member of our Board since May 2024 and previously served as a member of the Former Parent s board of directors from October 2021 until May 2024. Since January 2023, she has served as President and Chief Executive Officer and a member of the board of directors of Sanford Laboratories for Innovative Medicines, an independent, not-for-profit biomedical research institution with a mission to discover and deliver the next-generation of molecular medicines. Since January 1995, Dr. Vuori has also served as Professor, and since January 2010 as Pauline and Stanley Foster Distinguished Chair, at the National Cancer Institute-designated Cancer Center of Sanford Burnham Prebys Medical Discovery Institute ( SBP ), a non-profit research organization with major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. In addition, Dr. Vuori served as President and a member of the board of directors of SBP from January 2010 to June 2022 and as SBP s interim Chief Executive Officer from January 2013 to September 2014 and September 2017 to June 2020. She also served as SBP s Executive Vice President for Scientific Affairs from 2008 to 2010, Director of the Cancer Center from 2005 to 2013, and Deputy Director of the Cancer Center from 2003 to 2005. Dr. Vuori has previously served or is currently serving on the board of directors of Sanford Burnham Prebys Medical Discovery Institute, Tract Bio, Bionano Genomics, Inc., Sio Gene Therapies, Inc., Forian Inc., WebMD Health Corp, Inc., the American Association for Cancer Research, the California Institute for Regenerative Medicine and the California Breast Cancer Research Program. Dr. Vuori received her M.D. and Ph.D. from the University of Oulu, Finland. We believe that Dr. Vuori s experience as a physician-scientist in biomedical research and drug discovery and as an educator of research scientists, her experience managing a large non-profit biomedical research organization, and her various leadership roles in non-profit, for-profit, and public boards qualify her to serve as a member of our Board.